Search Results - "Joffrion, J L"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    The international normalized ratio during concurrent warfarin and argatroban anticoagulation : Differential contributions of each agent and effects of the choice of thromboplastin used

    The international normalized ratio during concurrent warfarin and argatroban anticoagulation : Differential contributions of each agent and effects of the choice of thromboplastin used by HURSTING, M. J, ZEHNDER, J. L, JOFFRION, J. L, BECKER, J.-C, KNAPPENBERGER, G. D, SCHWARZ, R. P

    Published in Clinical chemistry (Baltimore, Md.) (01-03-1999)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor

    Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor by Hursting, M J, Alford, K L, Becker, J C, Brooks, R L, Joffrion, J L, Knappenberger, G D, Kogan, P W, Kogan, T P, McKinney, A A, Schwarz, Jr, R P

    Published in Seminars in thrombosis and hemostasis (01-01-1997)
    “…Because of the unsatisfactory options available for safe and effective antithrombotic therapy, recent, intense research and development efforts have focused on…”
    Get more information
    Journal Article
    Save to List
    Saved in:
  3. 3
    The Effects of Intravaginal Clindamycin and Metronidazole Therapy on Vaginal Mobiluncus Morphotypes in Patients With Bacterial Vaginosis

    The Effects of Intravaginal Clindamycin and Metronidazole Therapy on Vaginal Mobiluncus Morphotypes in Patients With Bacterial Vaginosis by NYIRJESY, PAUL, MCINTOSH, MATTHEW J., STEINMETZ, JANA I., SCHUMACHER, ROBERT J., JOFFRION, JAMES L.

    Published in Sexually transmitted diseases (01-04-2007)
    “…Objective: The objective of this study was to compare the effects of treatments for bacterial vaginosis (BV) on vaginal Mobiluncus morphotypes. Study Design:…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis

    The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis by Nyirjesy, Paul, McIntosh, Matthew J., Gattermeir, David J., Schumacher, Robert J., Steinmetz, Jana I., Joffrion, James L.

    “…The purpose of this study was to determine the effects of 3 intravaginal antibacterial treatments on vaginal lactobacilli in patients with bacterial vaginosis…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    An open-label, two-period, crossover study of the systemic bioavailability in healthy women of clindamycin phosphate from two vaginal cream formulations

    An open-label, two-period, crossover study of the systemic bioavailability in healthy women of clindamycin phosphate from two vaginal cream formulations by Saul Levinson, R., Mitan, Steven J., Steinmetz, Jana I., Gattermeir, David J., Schumacher, Robert J., Joffrion, James L.

    Published in Clinical therapeutics (01-12-2005)
    “…A clindamycin phosphate 2% single-dose vaginal cream (CSDVC) formulation has been designed to provide release of clindamycin equivalent to 7 daily doses of a…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: